The essential oils obtained by hydrodistillation from leaves and flowers of Montanoa speciosa collected in southeastern Mexico (Yucatan) were analyzed by GC-MS. A total of 71 and 79 components, representing 98.44% and 97.69% of the leaf and flower oils, respectively, were characterized. The main constituents found were β-caryophyllene (20.73%, 17.95%), δ-cadinene (9.88%, 9.28%), caryophyllene oxide (9.48%, 8.68%), and germacrene D (6.94%, 5.85%). The essential oils were screened for their antioxidant potentials by DPPH assay. The leaves oil exhibited higher DPPH scavenging capability (72.85 ± 0.28 mmol TE/g essential oil and 147.83 ± 0.41 mg/mL Vit C/g essential oil) than the floral oil (68.43 ± 0.10 mmol TE/g essential oil and 131.59 ± 0.87 mg/mL Vit C/g essential oil).

Phenolic compounds and major steviol glucosides by HPLC-DAD-RP and invitro evaluation of the biological activity of aqueous and ethanolic extracts of leaves and stems: S.rebaudiana Bertoni (creole variety INIFAP C01),

No abstract

We developed a naringenin–hesperidin molar mixture (MIX–160) with proven antihyperglycemic and vasorelaxant activity in preclinical studies. A solid dosage form was manufactured to improve the bioavailability properties. In the current study, we sought to evaluate the oral preclinical toxicity of the MIX–160 dosage form, which showed no mortality or significant changes in the body weight, food consumption and tissue/organ mass in rats. Three daily oral doses (50, 300 and 2000 mg/kg of MIX–160) were assayed for 28 days. The results showed no structural abnormalities in the histological analysis and no significant changes (p > 0.05) in the liver biochemical markers (total bilirubin, AST and ALT) compared to the control group. The above findings showed that the MIX–160 dosage form did not exhibit relevant toxic effects, which suggests its potential safety as a drug candidate for clinical studies.